BetterInvesting's April Stock Study is Questcor Pharmaceuticals, Inc. (QCOR)
St. Louis Chapter of BetterInvesting sponsors the monthly stock study to provide an opportunity for the PUBLIC to join us in the lively discussion of a different stock each month. Led by Directors of the STL Chapter – Brian Hayek, Darlene Bonsanti and Candace Baker, the interactive group will discuss Questcor Pharmaceuticals, Inc. (QCOR). Founded in 1990 in California, the company is known for Acthar, a Multiple Sclerosis (MS) drug. Acthar has been a success, selling drug for MS, and now has been found to have many more uses. QCOR also is known for Doral for insomnia. Selling in the low $30.s the yield has been 3.1% per share and recently its dividend was raised by 25%. However, QCOR is not without risks, e.g., an investigation is underway into its pricing methods and competition. You may want to look at QCOR in Morningstar, Yahoo Finance and Value Line so you can add to the discussion – or just come listen. No investment experience necessary.
BetterInvesting is a non-profit educational organization since 1951. Our mission is to provide a program of sound investment information, education and support to create successful lifetime investors. We are holding Open House at www.betterinvesting.org/openhouse. Come visit!
Saint Louis, MO 63131
Comments powered by Disqus